LG Chem Life Sciences USA

뒷 페이지 앞 페이지
  • LG Chem
  • LG Chem
  • LG Chem
LG Chem Life Sciences
USA

LG Chem is a leading global company headquartered in South Korea, with a diversified business portfolio in the key areas of petrochemicals, advanced materials, and life sciences.

As one of LG Chem’s core businesses, LG Chem Life Sciences has developed a diversified portfolio across multiple therapeutic areas and modalities, steadfast in its commitment to fulfill its mission of transforming people’s lives through inspiring science and leading innovation.

Today, LG Chem Life Sciences is engaged in the development, manufacturing and commercialization of pharmaceutical products globally, and is committed to further expanding its global footprint by focusing on the key therapeutic areas of oncology, immunology, and metabolic diseases.

LG Chem Life Sciences USA, formerly LG Chem Life Sciences Innovation Center, is the hub of LG Chem Life Sciences based in the United States. Founded in 2019 within the world’s largest life sciences hub, Boston, MA, LG Chem Life Sciences USA is dedicated to extending the reach of LG Chem’ medicines and therapeutics to the U.S. and globally. Engaged in open innovation and strategic investments, LG Chem Life Sciences USA is set out to accelerate innovations and the development and commercialization of world-class therapies at LG Chem.

LG Chem acquired AVEO Oncology in January 2023 in line with its vision to become a global leader in oncology with a robust pipeline of innovative therapies aimed at improving the quality of patients' lives. AVEO Oncology is a Boston-based commercial stage, oncology-focused biopharmaceutical company. Read more about the acquisition here.

LG Chem Life Sciences
USA

LG Chem is a leading global company headquartered in South Korea, with a diversified business portfolio in the key areas of petrochemicals, advanced materials, and life sciences.

As one of LG Chem’s core businesses, LG Chem Life Sciences has developed a diversified portfolio across multiple therapeutic areas and modalities, steadfast in its commitment to fulfill its mission of transforming people’s lives through inspiring science and leading innovation.

Today, LG Chem Life Sciences is engaged in the development, manufacturing and commercialization of pharmaceutical products globally, and is committed to further expanding its global footprint by focusing on the key therapeutic areas of oncology, immunology, and metabolic diseases.

LG Chem Life Sciences USA, formerly LG Chem Life Sciences Innovation Center, is the hub of LG Chem Life Sciences based in the United States. Founded in 2019 within the world’s largest life sciences hub, Boston, MA, LG Chem Life Sciences USA is dedicated to extending the reach of LG Chem’ medicines and therapeutics to the U.S. and globally. Engaged in open innovation and strategic investments, LG Chem Life Sciences USA is set out to accelerate innovations and the development and commercialization of world-class therapies at LG Chem.

LG Chem acquired AVEO Oncology in January 2023 in line with its vision to become a global leader in oncology with a robust pipeline of innovative therapies aimed at improving the quality of patients' lives. AVEO Oncology is a Boston-based commercial stage, oncology-focused biopharmaceutical company. Read more about the acquisition here.

Mission

We Transform Lives
by Inspiring Sciences and Leading Innovation

LG Chem Life Sciences USA’s aim is to create therapeutic advances
using an open innovation model
and focusing on patient-centered product development

Core Value

  • LG Chem

    Teamwork

    Working together
    with mutual respect

  • LG Chem

    Agility

    Being proactive and
    moving forward, facing both the risks and opportunities

  • LG Chem

    Creativity

    Differentiated
    approach

  • LG Chem

    Challenge

    Achieving
    the impossible